Iyer Radhakrishnan P.

Director at F-star Therapeutics, Inc. · on record since May 20, 2016
Chief Scientific Officer at F-star Therapeutics, Inc. · on record since May 20, 2016

Insider trading activity of Iyer Radhakrishnan P.

Transactions on record: 10; since May 20, 2016

Open-market buys: 0

Open-market sells: 1; $833

Companies traded: 1; last filing Nov 23, 2020

Figures computed from official regulatory filings — .

Companies where Iyer Radhakrishnan P. has traded

F-star Therapeutics, Inc.10 tx · $833 · Nov 23, 2020

Track record of Iyer Radhakrishnan P.

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Iyer Radhakrishnan P.

Co-insiders of Iyer Radhakrishnan P.

Afdhal Nezam H.F-star Therapeutics, Inc.
Arkowitz DavidF-star Therapeutics, Inc.
BARDON CHRISTIANAF-star Therapeutics, Inc.
Bates JonathanF-star Therapeutics, Inc.
Benz Edward JRF-star Therapeutics, Inc.
Bermingham NessanF-star Therapeutics, Inc.
Brady Todd CF-star Therapeutics, Inc.
Brewis NeilF-star Therapeutics, Inc.
CLACKSON TIMOTHY PF-star Therapeutics, Inc.
DEPTULA-HICKS DARLENE MF-star Therapeutics, Inc.
Driscoll Martin JF-star Therapeutics, Inc.
Eichler Kurt MF-star Therapeutics, Inc.
Firmani LoriF-star Therapeutics, Inc.
Forster EliotF-star Therapeutics, Inc.
Freve JonathanF-star Therapeutics, Inc.
Kayitalire LouisF-star Therapeutics, Inc.
Klein Pamela M.F-star Therapeutics, Inc.
Krol Patrick Johan HendrikF-star Therapeutics, Inc.
MPM Oncology Impact Management GP LLCF-star Therapeutics, Inc.
MPM Oncology Impact Management LPF-star Therapeutics, Inc.
Oncology Impact Fund (Cayman) Management L.P.F-star Therapeutics, Inc.
Race GeoffreyF-star Therapeutics, Inc.
Smith Scott AndrewF-star Therapeutics, Inc.
UBS Oncology Impact Fund L.P.F-star Therapeutics, Inc.
Winslow GarrettF-star Therapeutics, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Company	Filed	Type	Qty	Price	Value · USD	Src
F-star Therapeutics, Inc.Listing unverified	Nov 23, 2020	Award	12,500	—	n/a (No price was disclosed in the filing)	SEC
F-star Therapeutics, Inc.Listing unverified	Nov 23, 2020	Exercise	5,000	—	n/a (No price was disclosed in the filing)	SEC
F-star Therapeutics, Inc.Listing unverified	Nov 23, 2020	ExerciseD (derivative)	-5,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
F-star Therapeutics, Inc.Listing unverified	Nov 23, 2020	Sell	-175	4.76 USD	$833	SEC
F-star Therapeutics, Inc.Listing unverified	Mar 9, 2020	AwardD (derivative)	20,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
F-star Therapeutics, Inc.Listing unverified	Mar 9, 2020	AwardD (derivative)	20,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
F-star Therapeutics, Inc.Listing unverified	Jan 25, 2019	AwardD (derivative)	45,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
F-star Therapeutics, Inc.Listing unverified	Jan 17, 2018	AwardD (derivative)	40,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
F-star Therapeutics, Inc.Listing unverified	Feb 10, 2017	AwardD (derivative)	40,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
F-star Therapeutics, Inc.Listing unverified	May 20, 2016	AwardD (derivative)	5,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
F-star Therapeutics, Inc.Listing unverified	Nov 23, 2020	Award	12,500	—	n/a (No price was disclosed in the filing)	SEC
F-star Therapeutics, Inc.Listing unverified	Nov 23, 2020	Exercise	5,000	—	n/a (No price was disclosed in the filing)	SEC
F-star Therapeutics, Inc.Listing unverified	Nov 23, 2020	ExerciseD (derivative)	-5,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
F-star Therapeutics, Inc.Listing unverified	Nov 23, 2020	Sell	-175	4.76 USD	$833	SEC
F-star Therapeutics, Inc.Listing unverified	Mar 9, 2020	AwardD (derivative)	20,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
F-star Therapeutics, Inc.Listing unverified	Mar 9, 2020	AwardD (derivative)	20,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
F-star Therapeutics, Inc.Listing unverified	Jan 25, 2019	AwardD (derivative)	45,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
F-star Therapeutics, Inc.Listing unverified	Jan 17, 2018	AwardD (derivative)	40,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
F-star Therapeutics, Inc.Listing unverified	Feb 10, 2017	AwardD (derivative)	40,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
F-star Therapeutics, Inc.Listing unverified	May 20, 2016	AwardD (derivative)	5,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC